Futura Medical plc announce headline results from its efficacy study of the Company's novel gel for the treatment of erectile dysfunction
投稿日:
September 21, 2016
<p></p>
Futura Medical plc announce headline results from its efficacy study of the Company's novel gel for the treatment of erectile dysfunction
The study comprised a total of 232 randomised males and it measured, as its primary endpoint, improvement in the erectile function ("EF") domain score of the International Index of Erectile Function ("IIEF"), the scoring system used for the approval of PDE5 inhibitors such as Viagra®. The study was of a placebo-controlled, double blind, home use, crossover design.View news article
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
-min.jpg)
.jpg)
